Discovery of Non-ATP-Competitive Inhibitors of Polo-like Kinase 1

详细信息    查看全文

• 作者：Taikangxiang Yun ; Tan Qin ; Prof. Ying Liu and Prof. Luhua Lai
• 关键词：inhibitors ; kinase domain ; non-ATP binding site ; polo-like kinase 1 ; virtual screening
• 刊名：ChemMedChem
• 出版年：2016
• 出版时间：April 5, 2016
• 年：2016
• 卷：11
• 期：7
• 页码：713-717
• 全文大小：1149K
• ISSN：1860-7187

文摘

Polo-like kinase 1 (Plk1) is an evolutionarily conserved serine/threonine kinase, and its N-terminal kinase domain (KD) controls cell signaling through phosphorylation. Inhibitors of Plk1 are potential anticancer drugs. Most known Plk1 KD inhibitors are ATP-competitive compounds, which may suffer from low selectivity. In this study we discovered novel non-ATP-competitive Plk1 KD inhibitors by virtual screening and experimental studies. Potential binding sites in Plk1 KD were identified by using the protein binding site detection program Cavity. The identified site was subjected to molecular-docking-based virtual screening. The activities of top-ranking compounds were evaluated by in vitro enzyme assay with full-length Plk1 and direct binding assay with Plk1 KD. Several compounds showed inhibitory activity, and the most potent was found to be 3-((2-oxo-2-(thiophen-2-yl)ethyl)thio)-6-(pyridin-3-ylmethyl)-1,2,4-triazin-5(4H)-one (compound 4) with an IC₅₀ value of 13.1±1.7 μm. Our work provides new insight into the design of kinase inhibitors that target non-ATP binding sites.